L. Galante

951 total citations
21 papers, 692 citations indexed

About

L. Galante is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, L. Galante has authored 21 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in L. Galante's work include Vitamin D Research Studies (4 papers), Bone health and treatments (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). L. Galante is often cited by papers focused on Vitamin D Research Studies (4 papers), Bone health and treatments (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). L. Galante collaborates with scholars based in United Kingdom, Switzerland and Italy. L. Galante's co-authors include I. MacIntyre, E.W. Matthews, Kay W. Colston, Nicholas Woodhouse, T. V. Gudmundsson, Amy Tse, P. G. H. Byfield, S. J. MacAuley, E. Spanos and I. M. A. Evans and has published in prestigious journals such as Nature, The Lancet and FEBS Letters.

In The Last Decade

L. Galante

20 papers receiving 573 citations

Peers

L. Galante
I. M. A. Evans United Kingdom
K. Henze United States
Fischer Ja Switzerland
Anthony D. Care United Kingdom
FLOR L. GEOLA United States
William P. Deiss United States
E. Keck Germany
J. M. Jacobi Australia
L. Galante
Citations per year, relative to L. Galante L. Galante (= 1×) peers Sven Almqvist

Countries citing papers authored by L. Galante

Since Specialization
Citations

This map shows the geographic impact of L. Galante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Galante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Galante more than expected).

Fields of papers citing papers by L. Galante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Galante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Galante. The network helps show where L. Galante may publish in the future.

Co-authorship network of co-authors of L. Galante

This figure shows the co-authorship network connecting the top 25 collaborators of L. Galante. A scholar is included among the top collaborators of L. Galante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Galante. L. Galante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hillyard, Carmel J., R. Charles Coombes, P. B. Greenberg, L. Galante, & I. MacIntyre. (1976). CALCITONIN IN BREAST AND LUNG CANCER. Clinical Endocrinology. 5(1). 1–8. 35 indexed citations
2.
Hillyard, Carmel J., R. Charles Coombes, P. B. Greenberg, L. Galante, & I. MacIntyre. (1976). CALCITONIN IN BREAST AND LUNG CANCER. Clinical Endocrinology. 5(1). 1–8. 1 indexed citations
3.
Coombes, R. Charles, Morag L. Ellison, G C Easty, et al.. (1976). THE ECTOPIC SECRETION OF CALCITONIN BY LUNG AND BREAST CARCINOMAS. Clinical Endocrinology. 5(s1). 387S–396S. 15 indexed citations
4.
Spanos, E., et al.. (1976). Effect of prolactin on vitamin D metabolism. Molecular and Cellular Endocrinology. 5(3-4). 163–167. 116 indexed citations
5.
Coombes, R. Charles, G C Easty, Simone Detre, et al.. (1975). Secretion of immunoreactive calcitonin by human breast carcinomas.. BMJ. 4(5990). 197–199. 48 indexed citations
6.
Evans, I. M. A., K W Colston, L. Galante, & I. MacIntyre. (1975). Feedback Regulation of 25-Hydroxycholecalciferol Metabolism by Vitamin D3. Clinical Science. 48(3). 227–230. 13 indexed citations
7.
Matthews, E.W., P. G. H. Byfield, Kay W. Colston, et al.. (1974). Separation of hydroxylated derivatives of vitamin D3 by high speed liquid chromatography (HSLC). FEBS Letters. 48(1). 122–125. 13 indexed citations
8.
Greenberg, P. B., Carmel J. Hillyard, L. Galante, et al.. (1974). Affinity of Calciferol Analogues for 25-Hydroxycholecalciferol Receptors. Clinical Science. 46(1). 143–147. 13 indexed citations
9.
Galante, L., K. W. Colston, I. M. A. Evans, et al.. (1974). The Regulation of Vitamin D Metabolism. Clinical Science. 46(2). 9P–10P. 5 indexed citations
10.
Galante, L., Kay W. Colston, I. M. A. Evans, et al.. (1973). The Regulation of Vitamin D Metabolism. Nature. 244(5416). 438–440. 64 indexed citations
11.
Galante, L., G. F. Joplin, I. MacIntyre, & Nicholas Woodhouse. (1973). The Calcium Lowering Effect of Synthetic Human, Porcine, and Salmon Calcitonin in Patients with Paget's Disease. Clinical Science. 44(6). 605–610. 26 indexed citations
12.
Galante, L., Richard Horton, G. F. Joplin, Nicholas Woodhouse, & I. MacIntyre. (1971). Comparison of Human, Porcine and Salmon Synthetic Calcitonins in Man and the Rat. Clinical Science. 40(3). 9P–10P. 15 indexed citations
13.
Reiner, Martin F., et al.. (1970). Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy.. PubMed. Suppl 50:136–Suppl 50:136. 1 indexed citations
14.
Woodhouse, Nicholas, Maureen Reiner, Dike N. Kalu, et al.. (1970). Remissions in Paget's Disease Produced by Human Synthetic Calitonin (Calcitonin M). Clinical Science. 39(3). 9P–10P. 1 indexed citations
15.
Byfield, P. G. H., L. Galante, T. V. Gudmundsson, et al.. (1969). The isolation of human calcitonin. Biochemical Journal. 111(3). 13P–14P. 7 indexed citations
16.
Galante, L., et al.. (1969). Biochemical studies on four patients with medullary carcinoma of the thyroid.. PubMed. 45(1). Suppl:xvi–Suppl:xvi. 2 indexed citations
17.
Moseley, Jane M., et al.. (1968). THE ULTIMOBRANCHIAL ORIGIN OF CALCITONIN. The Lancet. 291(7534). 108–110. 94 indexed citations
18.
Galante, L., T. V. Gudmundsson, E.W. Matthews, et al.. (1968). THYMIC AND PARATHYROID ORIGIN OF CALCITONIN IN MAN. The Lancet. 292(7567). 537–539. 58 indexed citations
19.
Cunliffe, W.J., Martin M. Black, R. Hall, et al.. (1968). A CALCITONIN-SECRETING THYROID CARCINOMA. The Lancet. 292(7559). 63–66. 102 indexed citations
20.
Riniker, B., R. Neher, R. Maier, et al.. (1968). Menschliches Calcitonin I. Isolierung und Charakterisierung. Helvetica Chimica Acta. 51(7). 1738–1742. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026